CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to COAG

HMB-002 with Concomitant Factor Concentrate (Part C) (Not Applicable in US)

Phase 2
Hemab Therapeutics Holdings, Inc. (COAG)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Von Willebrand Disease (VWD)

View Full Landscape
Drug Information

Target Indication

Von Willebrand Disease (VWD)

Clinical Trial

NCT06754852

Last updated: 10/21/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.